News
StockStory.org on MSN18h
AMRX Q1 Earnings Call: Miss on Revenue, Margin Expansion, and Product Pipeline ProgressPharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) in Q1 CY2025, but sales rose 5.5% year on year to $695.4 million. On the other hand, the company’s full-year revenue guidance of $3.05 ...
StockStory.org on MSN1d
MGPI Q1 Earnings Call: Revenue Tops Expectations, Margin Pressures Remain Amid Strategic RefocusingFood and beverage supplier MGP Ingredients (NASDAQ:MGPI) reported in Q1 CY2025, but sales fell by 28.7% year on year to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback